Physician

Ahmad Yusuf Solaiman, M.D.

According to 2025 Medicare claims, Ahmad Solaiman, M.D. (NPI: 1598151284) practices neurology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is HENRY FORD HEALTH SYSTEM (NPI: 1669533865; TIN: 38-1357020) and primary practice location at 48202-2608. Solaiman is affiliated with the Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Solaiman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 140 traditional Medicare patients, billed 215 HCPCS/CPT codes, and received $14,405 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 1,213 prescription claims across 176 beneficiaries totaling $447,405 in drug costs, led by Briviact (Brivaracetam). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $13,299 and ending at $14,405. Concurrently, Part D prescription costs have risen steadily, from $1,179 to $447,405. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$15K$30K2020 Medicare payment: $13,299 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $29,765 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $18,901 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $24,009 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $14,405 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202084135$13,299
2021203328$29,765
2022162212$18,901
2023156257$24,009
2024140215$14,405

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$224K$447K2015 Drug cost: $1,179 (USD; Tot_Drug_Cst)2016 Drug cost: $1,740 (USD; Tot_Drug_Cst)2017 Drug cost: $49,539 (USD; Tot_Drug_Cst)2018 Drug cost: $13,374 (USD; Tot_Drug_Cst)2019 Drug cost: $11,308 (USD; Tot_Drug_Cst)2020 Drug cost: $14,367 (USD; Tot_Drug_Cst)2021 Drug cost: $185,482 (USD; Tot_Drug_Cst)2022 Drug cost: $239,753 (USD; Tot_Drug_Cst)2023 Drug cost: $377,373 (USD; Tot_Drug_Cst)2024 Drug cost: $447,405 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151229$1,179
20162681$1,740
201747186$49,539
201852183$13,374
201943154$11,308
20202757$14,367
2021105596$185,482
2022144999$239,753
20232001,225$377,373
20241761,213$447,405

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95720Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional2136$154
95718Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional1818$97
95816Measurement of brain wave activity (eeg), awake and drowsy4848$41
95819Measurement of brain wave activity (eeg), awake and asleep1616$39
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's2225$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BriviactBrivaracetam872,546$143,745
EpidiolexCannabidiol (Cbd)24707$88,512
VimpatLacosamide29870$39,320
ValtocoDiazepam15450$21,174
LacosamideLacosamide1777,155$13,964

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Ahmad Yusuf Solaiman, M.D.?

Tedicare shows public-source Medicare data for Ahmad Yusuf Solaiman, M.D. (NPI 1598151284), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Yusuf Solaiman, M.D. have ACO affiliation data?

Ahmad Yusuf Solaiman, M.D. is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Ahmad Yusuf Solaiman, M.D.?

Ahmad Yusuf Solaiman, M.D. is linked to HENRY FORD HEALTH SYSTEM (billing NPI 1669533865) in the available physician profile data.

Does Ahmad Yusuf Solaiman, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.